首页|血清γ干扰素、软骨组织糖蛋白水平对脓毒症休克不良预后的预测价值

血清γ干扰素、软骨组织糖蛋白水平对脓毒症休克不良预后的预测价值

扫码查看
目的 分析血清γ干扰素(IFN-γ)、软骨组织糖蛋白(YKL-40)水平对脓毒症休克病人不良预后的预测价值.方法 前瞻性选取2020年12月至2022年12月在延安市人民医院就诊的86例脓毒症休克病人,另选取同期脓毒症病人80例,同期体检健康者90例为对照,酶联免疫法检测血清IFN-γ、YKL-40水平,比较病人血清IFN-γ、YKL-40水平和临床资料.Pearson法对血清IFN-γ、YKL-40水平及其与血清乳酸、血清白蛋白、SOFA评分、APACHE Ⅱ评分相关性进行分析;Cox回归分析脓毒症休克病人死亡的影响因素;ROC曲线分析IFN-γ、YKL-40对脓毒症休克病人预后预测价值.结果 脓毒症休克病人、脓毒症病人和体检健康者血清IFN-γ[(30.26±3.85)ng/L、(22.87±3.76)ng/L、(10.75±3.51)ng/L]、YKL-40[(217.58±40.03)μg/L、(178.43±39.25)μg/L、(119.02±38.76)μg/L]水平依次降低,生存组脓毒症休克病人血清IFN-γ[(28.67±3.84)ng/L比(34.38±3.88)ng/L]、YKL-40[(201.76±40.02)μg/L比(258.45±40.06)μg/L]水平显著低于死亡组病人(P<0.05).生存组和死亡组脓毒症休克病人呼吸频率、血清白蛋白、SOFA评分、血清乳酸、APACHE Ⅱ评分比较,差异有统计学意义(P<0.05).血清IFN-γ与YKL-40水平呈正相关(r=0.41,P<0.001),血清IFN-γ、YKL-40水平与血清乳酸、SOFA评分、APACHE Ⅱ评分呈正相关,与血清白蛋白呈负相关(P<0.05).Cox回归分析结果显示,IFN-γ[HR=1.03,95%CI:(1.02,1.04)]、YKL-40[HR=1.12,95%CI:(1.06,1.18)]、血清乳酸[HR=1.21,95%CI:(1.11,1.33)]、血清白蛋白[HR=0.96,95%CI:(0.94,0.98)]、SOFA评分[HR=1.30,95%CI:(1.18,1.45)]、APACHEⅡ评分[HR=1.35,95%CI:(1.16,1.58)]是脓毒症休克病人死亡的影响因素(P<0.001).IFN-γ、YKL-40水平联合检测评估脓毒症休克病人死亡的AUC显著高于单项检测(ZIFN-γ-联合=2.47,P=0.014;ZYKL-40-联合=3.55,P<0.001),特异度和灵敏度为91.67%和91.94%.结论 脓毒症休克病人血清IFN-γ、YKL-40水平较高,与脓毒症休克病人死亡密切相关,可能作为脓毒症休克病人不良预后的潜在标志物.
The predictive value of serum IFN-γ and YKL-40 levels for poor prognosis in septic shock patients
Objective To analyze the predictive value of serum interferon-γ(IFN-γ)and cartilage tissue glycoprotein(YKL-40)lev-els on the poor prognosis of septic shock patients.Methods From December 2020 to December 2022,86 patients with Septic shock-who visited Yan'an People's Hospital were prospectively selected,while 80 patients with sepsis and 90 healthy individuals were select-ed as controls,serum IFN-γ and YKL-40 levels were detected by enzyme-linked immunoassay,and serum IFN-γ and YKL-40 levels and clinical data were compared.Serum IFN-γ and YKL-40 levels and their correlation with serum lactate,serum albumin,SOFA score,and APACHE Ⅱ score were analyzed by Pearson method.Cox regression was applied to analyze the influencing factors of mortal-ity in Septic shock patients.ROC was applied to analyze the prognostic value of serum IFN-γ and YKL-40 levels in patients with Septic shock.Results The serum IFN-γ[(30.26±3.85)ng/L,(22.87±3.76)ng/L,(10.75±3.51)ng/L]and YKL-40 levels[(217.58±40.03)μg/L,(178.43±39.25)μg/L,(119.02±38.76)μg/L]in Septic shock patients,pyemia patients,and healthy individuals decreased sequentially,the serum IFN-γ[(28.67±3.84)ng/L vs.(34.38±3.88)ng/L]and YKL-40 levels[(201.76±40.02)μg/L vs.(258.45±40.06)μg/L]in Septic shock patients in the survival group were obviously lower than those in the death group(P<0.05).There was a statistically obvious dif-ference in respiratory rate,serum lactate,serum albumin,SOFA score,and APACHE Ⅱ score between the survival group and the death group(P<0.05).Pearson analysis showed a positive correlation between serum IFN-γ and YKL-40 levels(r=0.41,P<0.001),while serum IFN-γ and YKL-40 levels were positively correlated with serum lactate,SOFA score,APACHE Ⅱ score,and negatively correlated with serum albumin(P<0.05).Cox regression analysis showed that IFN-γ[HR=1.03,95%CI:(1.02,1.04)],YKL-40[HR=1.12,95%CI:(1.06,1.18)],serum lactate[HR=1.21,95%CI:(1.11,1.33)],serum albumin[HR=0.96,95%CI:(0.94,0.98)],SOFA score[HR=1.30,95%CI:(1.18,1.45)],and APACHE Ⅱ score[HR=1.35,95%CI:(1.16,1.58)]were influencing factors for mortality in patients with Septic shock(P<0.001).The AUC of combined detection of IFN-γ and YKL-40 levels in evaluating mortality of sepsis shock patients was obvi-ously higher than that of single detection(ZIFN-γ-combination=2.47,P=0.014;ZYKL-40-combination=3.55,P<0.001),with specificity and sensitivity of 91.67%and 91.94%.Conclusion The serum levels of IFN-γ and YKL-40 in Septic shock patients are high,which are closely related to the prognosis of patients and may serve as potential biomarkers for the prognosis of Septic shock patients.

Shock,septicInterferon-γCartilage tissue glycoproteinPrognosis

贺外信、白娟

展开 >

延安市人民医院,重症医学科,陕西 延安 716000

延安市人民医院,急诊科,陕西 延安 716000

休克,脓毒性 γ干扰素 软骨组织糖蛋白 预后

2025

安徽医药
安徽省药学会

安徽医药

影响因子:1.941
ISSN:1009-6469
年,卷(期):2025.29(2)